Literature DB >> 3439904

Total sleep deprivation and Parkinson disease.

P H Bertolucci1, L A Andrade, J G Lima, E A Carlini.   

Abstract

Twelve Parkinson disease (PD) patients were submitted to a single night of total sleep deprivation (SD). Disease duration had a median of 5.1 years and all were using either anticholinergic or L-Dopa or the combination of both drugs. After SD there was an improvement of rigidity, bradykinesia, gait and posture disturbances and functional disability that remained significant for 2 weeks. No effect was observed on tremor. Concerning depressive symptoms, a significant difference was noted, that remained for one week. These results suggest that SD may be an useful procedure to improve PD symptomatology. It is discussed a possible change of dopaminergic receptors, induced by SD, to explain the improvement.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3439904     DOI: 10.1590/s0004-282x1987000300002

Source DB:  PubMed          Journal:  Arq Neuropsiquiatr        ISSN: 0004-282X            Impact factor:   1.420


  4 in total

1.  Inhibition of REM sleep by ipsapirone, a 5HT1A agonist, in normal volunteers.

Authors:  J C Gillin; W Jernajczyk; D C Valladares-Neto; S Golshan; M Lardon; S M Stahl
Journal:  Psychopharmacology (Berl)       Date:  1994-12       Impact factor: 4.530

2.  Persistent short-term memory defects following sleep deprivation in a drosophila model of Parkinson disease.

Authors:  Laurent Seugnet; James E Galvin; Yasuko Suzuki; Laura Gottschalk; Paul J Shaw
Journal:  Sleep       Date:  2009-08       Impact factor: 5.849

3.  Synergistic anticataleptic effect of imipramine and nicotine in a rotenone-induced rat model.

Authors:  Ilya D Ionov; Irina I Pushinskaya; Nicholas P Gorev; Larissa A Shpilevaya
Journal:  Psychopharmacology (Berl)       Date:  2019-05-08       Impact factor: 4.415

4.  Parkinson's disease, lights and melanocytes: looking beyond the retina.

Authors:  Gregory L Willis; Cleo Moore; Stuart Maxwell Armstrong
Journal:  Sci Rep       Date:  2014-01-29       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.